201 related articles for article (PubMed ID: 38717734)
21. Preclinical toxicity evaluation of novel antibacterial contezolid acefosamil in rats and dogs.
Wang W; Li Z; Gordeev MF; Yuan H
J Appl Toxicol; 2024 May; 44(5):770-783. PubMed ID: 38237604
[TBL] [Abstract][Full Text] [Related]
22. Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.
Falagas ME; Vardakas KZ
Drug Saf; 2008; 31(9):753-68. PubMed ID: 18707190
[TBL] [Abstract][Full Text] [Related]
23. Contezolid can replace linezolid in a novel combination with bedaquiline and pretomanid in a murine model of tuberculosis.
Almeida D; Li S-Y; Lee J; Hafkin B; Mdluli K; Fotouhi N; Nuermberger EL
Antimicrob Agents Chemother; 2023 Dec; 67(12):e0078923. PubMed ID: 37966090
[TBL] [Abstract][Full Text] [Related]
24. Tolerability and Pharmacokinetics of Contezolid at Therapeutic and Supratherapeutic Doses in Healthy Chinese Subjects, and Assessment of Contezolid Dosing Regimens Based on Pharmacokinetic/Pharmacodynamic Analysis.
Wu J; Wu H; Wang Y; Chen Y; Guo B; Cao G; Wu X; Yu J; Wu J; Zhu D; Guo Y; Yuan H; Hu F; Zhang J
Clin Ther; 2019 Jun; 41(6):1164-1174.e4. PubMed ID: 31126694
[TBL] [Abstract][Full Text] [Related]
25. Clinical Pharmacology and Utility of Contezolid in Chinese Patients with Complicated Skin and Soft-Tissue Infections.
Yuan H; Wu H; Zhang Y; Huang H; Li Y; Wu J; Cao G; Yu J; Guo B; Wu J; Yuan Z; Chen Y; Yang W; Wu X; Zhang J
Antimicrob Agents Chemother; 2022 Jun; 66(6):e0243021. PubMed ID: 35575579
[TBL] [Abstract][Full Text] [Related]
26. Contezolid, a novel oxazolidinone antibiotic, may improve drug-related thrombocytopenia in clinical antibacterial treatment.
Li B; Liu Y; Luo J; Cai Y; Chen M; Wang T
Front Pharmacol; 2023; 14():1157437. PubMed ID: 37168994
[TBL] [Abstract][Full Text] [Related]
27. Drug Degradation Caused by
Pi R; Chen X; Meng J; Liu Q; Chen Y; Bei C; Wang C; Gao Q
Antimicrob Agents Chemother; 2022 Oct; 66(10):e0103422. PubMed ID: 36190243
[TBL] [Abstract][Full Text] [Related]
28. Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
Douros A; Grabowski K; Stahlmann R
Expert Opin Drug Metab Toxicol; 2015; 11(12):1849-59. PubMed ID: 26457865
[TBL] [Abstract][Full Text] [Related]
29. Linezolid: an oxazolidinone antimicrobial agent.
Paladino JA
Am J Health Syst Pharm; 2002 Dec; 59(24):2413-25. PubMed ID: 12503340
[TBL] [Abstract][Full Text] [Related]
30. Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study.
Cepeda JA; Whitehouse T; Cooper B; Hails J; Jones K; Kwaku F; Taylor L; Hayman S; Shaw S; Kibbler C; Shulman R; Singer M; Wilson AP
J Antimicrob Chemother; 2004 Feb; 53(2):345-55. PubMed ID: 14711840
[TBL] [Abstract][Full Text] [Related]
31. In vivo pharmacodynamic study of contezolid acefosamil, a prodrug of contezolid for oral and intravenous administration.
Wang XK; Yu J; Xie CY; Hu XX; Nie TY; Li X; Wang PH; Li GQ; Yuan H; Yang XY; Li CR; You XF
J Antimicrob Chemother; 2023 Jul; 78(7):1632-1636. PubMed ID: 37202829
[TBL] [Abstract][Full Text] [Related]
32. Review of meta-analyses of vancomycin compared with new treatments for Gram-positive skin and soft-tissue infections: Are we any clearer?
Tsoulas C; Nathwani D
Int J Antimicrob Agents; 2015 Jul; 46(1):1-7. PubMed ID: 25982913
[TBL] [Abstract][Full Text] [Related]
33. Linezolid for gram-positive infections.
Drug Ther Bull; 2001 Jul; 39(7):54-6. PubMed ID: 11471517
[TBL] [Abstract][Full Text] [Related]
34. Clinical trial results with linezolid, an oxazolidinone, in the treatment of soft tissue and postoperative gram-positive infections.
Wilson SE
Surg Infect (Larchmt); 2001; 2(1):25-35. PubMed ID: 12594878
[TBL] [Abstract][Full Text] [Related]
35. Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.
Prokocimer P; Bien P; Surber J; Mehra P; DeAnda C; Bulitta JB; Corey GR
Antimicrob Agents Chemother; 2011 Feb; 55(2):583-92. PubMed ID: 21115795
[TBL] [Abstract][Full Text] [Related]
36. AZD-2563 AstraZeneca.
Johnson AP
Curr Opin Investig Drugs; 2002 Jun; 3(6):848-52. PubMed ID: 12137402
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics and Disposition of Contezolid in Humans: Resolution of a Disproportionate Human Metabolite for Clinical Development.
Wu X; Meng J; Yuan H; Zhong D; Yu J; Cao G; Liu X; Guo B; Chen Y; Li Y; Shi Y; Gordeev MF; Wu J; Zhang J
Antimicrob Agents Chemother; 2021 Oct; 65(11):e0040921. PubMed ID: 34398672
[TBL] [Abstract][Full Text] [Related]
38. [Role of linezolid in antimicrobial therapy].
Carmona PM; Romá E; Monte E; García J; Gobernado M
Enferm Infecc Microbiol Clin; 2003 Jan; 21(1):30-41. PubMed ID: 12550042
[TBL] [Abstract][Full Text] [Related]
39. Tedizolid: A New Oxazolidinone Antibiotic for Skin and Soft Tissue Infections.
Chahine EB; Sucher AJ; Knutsen SD
Consult Pharm; 2015 Jul; 30(7):386-94. PubMed ID: 26173190
[TBL] [Abstract][Full Text] [Related]
40. Linezolid for the treatment of resistant gram-positive cocci.
Bain KT; Wittbrodt ET
Ann Pharmacother; 2001 May; 35(5):566-75. PubMed ID: 11346064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
